| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/22/2002 | EP1206261A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 05/22/2002 | EP1206257A1 Use of amino acids for making medicines for treating to insulin-resistance |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1206190A1 Vaccines for the treatment of autoimmune disease |
| 05/22/2002 | EP1147107A4 Novel angiogenesis inhibitors |
| 05/22/2002 | EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 05/22/2002 | EP0583360B1 Compositions for the prevention and/or treatment of pathological processes |
| 05/22/2002 | CN1350548A Long lasting insulinotropic peptides |
| 05/22/2002 | CN1350466A A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes |
| 05/22/2002 | CN1350458A Protease inhibitors |
| 05/22/2002 | CN1350452A Preventive or therapeutic drugs for diabetes |
| 05/22/2002 | CN1349983A Non-peptide neomatal vascularization inhibitor |
| 05/22/2002 | CN1349820A Application of shinyleaf yellowhorn fruit shell in preparing cerbral function improving food and medicine |
| 05/22/2002 | CN1349806A Hypoglycemic and antiphthitic medicine for treating diabetes and phthisis |
| 05/22/2002 | CN1349805A Chinese medicine for treating diabetes and keto acid toxication |
| 05/22/2002 | CN1349804A Medicine for treating diabetes and eye disease |
| 05/22/2002 | CN1349803A Medicine for treating diabetes and coronary heart disease |
| 05/22/2002 | CN1349802A Diabetes treating medicine |
| 05/22/2002 | CN1349801A Yin nourishing and kidney reinforcing medicine |
| 05/22/2002 | CN1349795A Compound slimming prepn and its application |
| 05/22/2002 | CN1085250C Enzymatic hydroxylation process for the preparation HMG-CoA reductase inhibitors and intermediates thereof |
| 05/21/2002 | US6392071 Anticancer agents |
| 05/21/2002 | US6392042 Polyhydroxyalkylpyrazine derivatives, their preparation and medicaments comprising them |
| 05/21/2002 | US6391920 Administering hormone inhibitor; stimulant of testosterone |
| 05/21/2002 | US6391917 Analgesic |
| 05/21/2002 | US6391892 Naphthyl pharmaceutical compounds |
| 05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
| 05/21/2002 | US6391880 Anticholesterol agents |
| 05/21/2002 | US6391875 Pharmaceutically active morpholinol |
| 05/21/2002 | US6391864 Glucosamine mixtures |
| 05/21/2002 | US6391854 Water soluble hypoglycemic agents |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391852 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/21/2002 | US6391832 Medical emulsion for lubrication and delivery of drugs |
| 05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
| 05/16/2002 | WO2002038807A1 Method for screening agents capable of treating obesity |
| 05/16/2002 | WO2002038775A2 METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE |
| 05/16/2002 | WO2002038646A2 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038575A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 05/16/2002 | WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 05/16/2002 | WO2002038559A1 1,3-diazaheterocyclic compounds and their use as oral hypoglycaemic agents |
| 05/16/2002 | WO2002038553A2 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists |
| 05/16/2002 | WO2002038551A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 05/16/2002 | WO2002038544A2 3-substituted oxindole beta 3 agonists |
| 05/16/2002 | WO2002038543A2 3-substituted oxindole beta 3 agonists |
| 05/16/2002 | WO2002038541A1 Cyanopyrrolidine derivatives |
| 05/16/2002 | WO2002038180A1 High-density lipoprotein-cholesterol level elevating agent |
| 05/16/2002 | WO2002038171A2 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/16/2002 | WO2002038169A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | WO2002038166A2 Ginseng berry extracts and pharmaceutical compositions therefrom |
| 05/16/2002 | WO2002038165A1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
| 05/16/2002 | WO2002038151A1 Lipid peroxide-lowering compositions |
| 05/16/2002 | WO2002038140A2 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | WO2002038129A2 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 05/16/2002 | WO2002038106A2 Calcilytic compounds |
| 05/16/2002 | WO2002030891A8 Aliphatic nitrogenous five-membered ring compounds |
| 05/16/2002 | WO2002030890A8 Nitrogenous five-membered ring compounds |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002020488A3 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 05/16/2002 | WO2002017892A3 Water-dispersible encapsulated sterols |
| 05/16/2002 | WO2002011562A3 Nutritional supplement for the management of weight |
| 05/16/2002 | WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002090A3 Inhibitors of copper-containing amine oxidases |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments |
| 05/16/2002 | WO2001095890A3 Oral pharmaceutical compositions containing terbinafine |
| 05/16/2002 | WO2001088533A3 Lipid uptake assays |
| 05/16/2002 | WO2001087335A3 Method for selectively inhibiting ghrelin action |
| 05/16/2002 | WO2001083478A3 Hydantoin-containing glucokinase activators |
| 05/16/2002 | WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/16/2002 | WO2001076578A8 Treatment of icu-associated hypocalcemia with vitamin d compounds |
| 05/16/2002 | WO2001070663A3 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 05/16/2002 | WO2001045664A3 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 05/16/2002 | WO2001045663A3 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058709 For therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lungs |
| 05/16/2002 | US20020058708 Compositions containing hypotriglyceridemically active stilbenoids |
| 05/16/2002 | US20020058707 Compositions containing hypoglycemically active stilbenoids |
| 05/16/2002 | US20020058705 For use in therapy of hypercholesterolemia, as anti- ischemic and/or anti-thrombotic agent, as antiplatelet agent, or as agent against gastric ulcers induced by compounds, agents or drugs |
| 05/16/2002 | US20020058704 Multicomponent compositions containing chitosan and methods of preparing same |
| 05/16/2002 | US20020058700 Ion channel modulating agents |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058689 Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi]indole derivatives |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
| 05/16/2002 | US20020058671 Neuropeptide Y antagonists |
| 05/16/2002 | US20020058658 For use in therapy and prophylaxis of diabetes and obesity |
| 05/16/2002 | US20020058644 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
| 05/16/2002 | US20020058638 Decreasing blood glucose levels, inhibiting PEPCK expression, decreasing blood insulin levels, decreasing insulin resistance, increasing insulin sensitivity, decreasing blood triglyceride levels or decreasing blood cholesterol levels |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058065 Insoluble drug particle compositions with improved fasted-fed effects |